CCN2 reduction mediates protective effects of BMP7 treatment in obstructive nephropathy
Crossref DOI link: https://doi.org/10.1007/s12079-016-0358-2
Published Online: 2016-10-20
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Falke, Lucas L.
Leeuwis, Jan Willem
Lyons, Karen M.
Mummery, Christine L.
Nguyen, Tri Q.
Goldschmeding, Roel
Funding for this research was provided by:
Netherlands Institute for Regenerative Medicine (FES0908)
License valid from 2016-10-20